Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis

• Status: Unknown status
• Trial end date: 2018-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis.

This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Infliximab; Tumor Necrosis Factor Inhibitors

Criteria

Inclusion Criteria:

• active takayasu's arteritis

Exclusion Criteria:

• active Tuberculosis

• Liver function abnormality

• heart failure ( New York Heart Association III - IV)

• patients were not consented